Upon conclusion of this program, participants should be able to:

• Identify the optimal induction chemotherapy regimens for acute myeloid and lymphoid leukemia on a risk-based approach in 2010.
• Distinguish the appropriate candidates for and timing of allogeneic stem cell transplant in Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasms, and Chronic Myelogenous Leukemia in 2010.

Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.